Extraction Expertise for Medical Device Chemical Characterization
EAG offers advanced expertise and a risk-based approach for medical device extractable study design and execution, including the latest FDA expectations.
Eurofins Expands with Acquisition of Nanolab Technologies
Eurofins Scientific, a global scientific leader in bioanalytical testing, announces that it has signed a definitive agreement to acquire Nanolab Technologies, which provides complex knowledge based analytical services to a wide range of high-tech industries. The transaction is Eurofins’ second major acquisition in the rapidly growing materials science and high technology markets, and is a strong follow-up to its purchase of global scientific services company, EAG Laboratories, in December 2017.
Headquartered in the heart of the Silicon Valley, Nanolab Technologies delivers advanced materials and analytical solutions to a $3 billion high technology market comprised of equipment suppliers, original design manufacturers (ODMs) and original equipment manufacturers (OEMs).
The transaction should be immediately margin-accretive for Eurofins after closing. The deal is expected to close in the third quarter of 2018, subject to the fulfilment of regulatory and customary closing conditions.
Comment from John Traub, Nanolab Technologies President and CEO: “There has never been greater demand for smaller, lighter, high-performance products that do more and use less energy. Nanolab Technologies has earned a reputation in North America for delivering the fast, reliable testing and analyses that help drive innovation and quality. As part of Eurofins, we look forward to leveraging those strengths on a global scale.”
Comment from Dr. Gilles Martin, Eurofins CEO: “We are extremely pleased to welcome Nanolab Technologies and its employees to the Eurofins Group, and are enthusiastic about Eurofins’ growing footprint in high-technology sectors. Nanolab Technologies and its materials scientists, engineers and analysts complement the world-class capabilities acquired last year through EAG Laboratories. Its addition to the Eurofins group is testament to our commitment to meet the sophisticated analytical needs of product innovators around the world.”
For more information, please visit www.eurofins.com or contact:
Investor Relations
Eurofins Scientific
Phone: +32 2 766 1620
E-mail: ir@eurofins.com
More content you might like...
Complementary Techniques: X-Ray & SAM
Complementary Techniques: X-Ray & SAM X-ray imaging is a great non-destructive technique that is used in many industries to help visualize internal construction. Scanning acoustic microscopy (SAM) is another non-destructive
EAG Scientists Present Research at SciX 2024
EAG Scientists present research at SciX 2024 focused on compositional analysis and provenience studies of natural iron oxides pigments.
Frequently Asked Questions About In Vitro Irritation and Cytotoxicity Testing
Biocompatibility assessments are a battery of tests performed to evaluate a product, medical device, or other material for the risk of biological hazards.